Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study

INTRODUCTION: To compare the effects of ipragliflozin, a sodium-glucose transporter 2 inhibitor, with those of metformin on visceral fat (as well as muscles and bones) in Japanese elderly patients with type 2 diabetes (T2D), we conducted a sub-analysis of a prospective, multicenter, blinded-endpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshizaka, Masaya, Ishikawa, Ko, Ishibashi, Ryoichi, Takahashi, Sho, Sakamoto, Kenichi, Yokoh, Hidetaka, Baba, Yusuke, Ide, Shintaro, Ide, Kana, Ishikawa, Takahiro, Onishi, Shunichiro, Kobayashi, Kazuki, Takemoto, Minoru, Horikoshi, Takuro, Shimofusa, Ryota, Maezawa, Yoshiro, Yokote, Koutaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843837/
https://www.ncbi.nlm.nih.gov/pubmed/33098565
http://dx.doi.org/10.1007/s13300-020-00949-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843837/
https://www.ncbi.nlm.nih.gov/pubmed/33098565
http://dx.doi.org/10.1007/s13300-020-00949-0

Ejemplares similares